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httpcense.Abstract COPD and the OSAHS are both common diseases affecting respectively 10% and 5% of
the adult population over 40 years of age. Their coexistence, which is denominated as «overlap syn-
drome», can occur in about 0.5% of this population.
Aim and materials: To assess the existence of a prevalence of OSAHS in patients with COPD
through a prospective analysis: 70 had a conﬁrmed isolated OSAHS (group A) and 11 had an
OS (group B), all were compiled from January 2007 to June 2012.
Results: The prevalence of OS in our study was 13.6%, OS patients were older than the isolated
OSAHS patients (p< 0.05) with a male predominance in the Overlap arm (p< 0.05), and BMI was
similar between the 2 groups (p= 0.22). Tobacco is retained as a risk factor and 81.8% of patients
with Overlap were smoking (p< 0.05). Clinical signs most reported are nocturnal snoring and day-
time sleepiness. The Epworth Sleepiness Scale was higher than 10 in the 2 groups (p< 0.05). The
Berlin questionnaire realized in 30 subjects in group A, was positive (40% of cases) and was positive
in 63.6% of 7 subjects in group B. Spirometry showed that vital capacity, FEV1 and FEV1/CV were
signiﬁcantly decreased in the Overlap group (p< 0.001). The recording shows a sleep apnea–hypo-
pnea index (AHI) similar in the two groups (p< 0.05).
Conclusion: There was no correlation between COPD and OSAHS. The latter is a risk factor for
the ﬁrst.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.ina University Hospital, B.P.
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can expect that many subjects can simultaneously have COPD
and OSAHS by chance alone without one being a predisposing
condition for the development of other [1].
The authors thought that COPD favored the presence of
OSAHS [2], because the prevalence of OSAHS appeared high-
er in COPD than in the general population [3] and because
some etiological factors were considered as common to the
two conditions, like smoking. It was in fact suppositions from
studies that did not have a real epidemiological basis [3], and
the role of tobacco was evident in COPD, but less evident in
OSAHS.
It was necessary to wait until 2003 and the publication of
Sanders et al. [4] of the results of the Sleep Heart Health Study
(SHHS), so that we ﬁnally have solid epidemiological data
(5954 participants) on the coexistence of COPD and OSAHS.
These results were complemented in 2005 by the Polish study
of Bednarek et al. [5] that examined 676 volunteers from the
general population.
Aim and material
The aim of our study was to assess the prevalence of OSAHS
in patients with COPD through a prospective analysis: 130 pa-
tients referred for suspected sleep apnea have been sleep re-
corded. Subjects should have more than 30 years and have
no history of being treated with CPAP for OSAHS or to have
received oxygen therapy.
Obstructive airway disorder synonymous term COPD was
deﬁned by a FEV/FVC less than 70%. The diagnosis of
OSAHS was established according to the criteria of the Amer-
ican Academy of Sleep Medicine. All patients recruited into
the study were approved consent. 70 had isolated OSAHS con-
ﬁrmed (group A) and 11 had the association of OSAHS and
COPD (group B), the other 49 patients (necessarily to be
OSA+ and COPD, or OSA and COPD+) have not been
the object of this study that was done on a period of ﬁve years
and a half.
Methods
All of these epidemiological, clinical and paraclinical data has
been collected on a preset farm return. Statistical analysis wasperformed using SPSS software version 10.0 compatible with
Windows. Values <0.05 were considered statistically
signiﬁcant.
Results
Epidemiological data
The mean age of patients was 45.73 years ±11.47 years in
group A versus 54.18 ± 7.79 years in group B. The statisti-
cal difference was signiﬁcant. A female predominance
(57.2%) was observed in group A versus a male predomi-
nance in group B.
Clinical data
Tobacco is retained as a risk factor, 81.8% of patients OS were
smokers, with a difference that is statistically signiﬁcant
(p< 0.001). The clinical signs most reported similarly in both
groups are clinical signs of OSA. The scale of quality of life
was altered in 59 patients (84.3%) from group A and all pa-
tients in group B. The statistical difference between groups
was not signiﬁcant (p= 0.34). The Epworth sleepiness scale
was greater than 10 in favor of excessive daytime sleepiness
in 41 patients (58.6%) from group A and 8 subjects (72.7%)
from group B. The statistical difference between groups was
not signiﬁcant (p= 0.38). The Berlin Questionnaire (BQ) used
to evaluate the clinical probability of OSA was performed in
30 patients of group A and was positive (at least two positive
categories) in 28 subjects (40%) for a high probability of sleep
apnea, while in group B: 7 subjects had a positive BQ (63.6%).
The body mass index (BMI) was similar in both groups
(p= 0.22).
Paraclinical data
Spirometry: The results are schematized in Table 1.
Polygraphic and/or polysomnographic recording:
The choice was based on the clinical context
primarily guided by the clinical suspicion (missing or loud
ventilatory polygraphy, low: polysomnography). The polyg-
raphy was performed in 70 subjects in both groups
(86.42%) versus 11 patients (13.58%) who have beneﬁted
Table 1 Spirometric results of patients with the overlap syndrome (group B) compared with patients with OSAHS isolated (group A).
Spirometry Group A, Number (%) Group B, Number (%) p
Normal 55 (78.6) 0
FVC (% predicted) 87.05 ± 14.32 78.28 ± 8.59 0.01
FEV (l) 2.82 ± 0.58 1.49 ± 0.22 <0.001
FEV (% predicted) 88.03 ± 14.62 59.63 ± 6 <0.001
FEV/CV (%) 85.86 ± 11.69 56.87 ± 6.43 <0.001
Table 2 Results of the sleep recording of patients with overlap syndrome (group B) compared with patients with OSAHS isolated
(group A).
Group A, Number (%) Group B, Number (%) p
AHI (events/hour) 21.8 ± 15.8 21.05 ± 8.74 0.88
Severity of OSAHS 0.53
 Mild 28 (40) 2 (18.2)
 Moderate 24 (34.3) 6 (54.5)
 Severe 18 (25.7) 3 (27.3)
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Table 2.Discussion
It was David Flenley who ﬁrst used over 20 years ago, the term
of overlap syndrome to describe the association of COPD and
OSAHS [6]. He estimated that this association of two common
diseases probably concerned many subjects. In practice, the
use of the term overlap syndrome was reserved to the associa-
tion of COPD and OSAHS.
Many recent epidemiological studies have concerned the
prevalence of COPD and OSAHS in the general population.
Obviously, studies of this type concerning overlap syndrome
are much rarer. The oldest study published on 1980 by the
Guilleminault group [2] which has a prevalence of OSAHS
objectiﬁed equal to 92% for a series of 26 COPD patients re-
ferred to a specialist sleep center because they complained of
excessive daytime sleepiness.
The studies of Bradley [7,8] and Chaouat [3] included pa-
tients in whom the diagnosis of OSAHS was put by polysom-
nography (respectively in 50 and 265 patients), the prevalence
of COPD reached 14% in the Bradley study [8] and 11% in the
Chaouat study [3]. In our study the prevalence of overlap syn-
drome was 13.6%. This prevalence is very different depending
on the used deﬁnition. The apparent differences between the
studies may be explained by differences in the selection criteria,
the characteristics of the population and conception of the
study [9].
We have two recent epidemiological studies of large-scale
and high-quality, made in the United States [4] and Poland
[5], whose objective is to appreciate the prevalence of OSAHS
in COPD and verify that this prevalence is higher or not in the
general population.
In the SHHS study [4] from the 5954 participants who
have had home polysomnography, 1138 subjects, equal to
19% had COPD. In the American epidemiological study
by American of Mannino [10], the distribution of mild,
moderate and severe COPD is not very different from the
SHHS.Bednarek et al. [5] found overlap syndrome in 7 subjects, or
1% of the cohort. This percentage is roughly equivalent to that
obtained on the basis of the prevalence of COPD and OSAHS
in the adult population of European countries.
The results of Sanders et al. [4] do not support the hypoth-
esis that COPD favors the coexistence of OSAHS and vice ver-
sa. If the overlap syndrome is relatively frequent, it is simply
because COPD and OSAHS were very common diseases.
If COPD is present in 10% of adults over 40 years [11–13]
and if the prevalence of OSAHS in the same population range
is of the order of 5–10% [14–16], the overlap syndrome can be
found in 0.5–1% of the population over 40 years, which is far
from negligible.
A certain number of studies compare the clinical character-
istics of OS patients with isolated OSA. Chaouat et al. [3]
found that compared to the isolated OSAHS group, OS popu-
lation tends to be older, but the BMI was similar in both
groups, which was reported in the SHHS study. O’Brien and
Whitman [17] found that patients with OS were also older
and less obese. The participants of the Monia study are
broadly comparable to the participants of the SHHS study
with some differences: younger subjects in all, discreet male
predominance in COPD patients, airway obstruction slightly
higher in COPD. The studies conducted by Radwan [18] and
Zamarron [19] found no signiﬁcant difference concerned the
severity of OSAHS, the mean arterial oxygen saturation dur-
ing sleep, and BMI. In our study, patients with OS were also
older than isolated OSA (p< 0.05) with a male predominance
in the Overlap arm (p< 0.05), there are no controlled studies
concerning the predominance of sex, and BMI was similar be-
tween the 2 groups (p= 0.22).
Association more frequent than expected by chance alone
between OSAHS and COPD may be explained by the fact that
the two conditions have a common etiological factor, smoking
for example. However, while the role of cigarette smoke is well
established in COPD [20,21], the role of smoking as a risk fac-
tor for OSAHS is discussed, considered negligible in some
studies [22,23], while for other studies suggest that the cigarette
smoke may increase the risk of obstructive apneas during sleep
[24–26]. In our series tobacco is retained as a risk factor, 81.8%
of patients with OS were smoking (p< 0.05).
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COPD showed no difference in sleep quality from that of the
general population of the same age. This is the case in the Le-
wis study [27] where COPD with nocturnal desaturation
(n= 29) did not have a different quality of sleep without noc-
turnal desaturation in COPD (n= 30). in the SHHS study
mentioned above [4] the 1138 COPD subjects (mild COPD pa-
tients on average) have no signiﬁcant electroencephalographic
objective perturbations of sleep if they were not associated
with OSAHS, moreover, the architecture of sleep is not differ-
ent in COPD patients with the FEV in the lowest quartile com-
pared with the FEV in the highest quartile. [4].
Sanders et al. [4] also observed that OS subjects compared
to subjects with isolated OSA have a most important sleepi-
ness, a lower total sleep time, a decreased sleep efﬁciency
and a higher arousal index. In contrast, there are virtually
no differences in quality and sleep architecture between sub-
jects with OSAHS subjects and isolated OSA [4]. In our study
the Epworth Sleepiness Scale did not differ between the two
groups (p= 0.38), so was the Berlin score used in certain pa-
tient groups.
Therefore, COPD itself does not affect the quality of sleep.
It is inﬂuenced by the presence of OSAHS, which was ex-
pected, but not by the severity of airway obstruction.
The OS patients in the Chaouat study [3] had lung volumes
and FEV/LVC lower than the subjects with Os recruited into
the epidemiological cohorts [4,5], this is also found in our
study since the CV, FEV, and FEV/CV were decreased in
the group OS compared with group isolated OSA, which is
quite logical because the recruitment criteria are very different
and the criteria for deﬁning COPD are not exactly the same
based on the FEV/FVC in epidemiological studies [4,5] and
the FEV/LVC in the Chaouat study [3]. The means ratio
FEV/LVC of 30 patients was 50 ± 6%, which is signiﬁcantly
lower than the ratio FEV/FVC of 63.8 ± 6.6% in subjects
with COPD in SHHS study [4], but this difference in the sever-
ity of airway obstruction is probably explained by the fact that
Chaouat et al. [3] have explored patients with consecutive
OSAHS, while the SHHS study examined on the general pop-
ulation. In our study the spirometric parameters were clearly
reduced in the the overlap syndrome group compared to the
isolated OSAHS group (see Table 1).
The most important ﬁnding of the SHHS study [4] is that
IAH is not higher in COPD patients than in not COPD pa-
tients. on the contrary, the COPD participants have a mean
and median AHI signiﬁcantly lower than not COPD partici-
pants [4], the AHI values are identical in the two groups [4],
the percentage of subjects with an AHI >10 or >15 is not
higher in COPD participants, rather it is a little lower in theirs
and statistically signiﬁcant.
As in the SHHS study, Chaouat et al. [3] and Bednarek et
al. [5] in their studies have not found more OSAHS in the
COPD group than in the not COPD group.
In our study AHI was similar in the two groups (p=0.88) and
clinical signs of OSAHS including daytime sleepiness and the Ep-
worth Sleepiness Scale were also similar in the both groups.
These results are not in favor of an increased prevalence of
OSAHS in COPD compared with the general population with-
out COPD. The coexistence of COPD and OSAHS is due to
chance rather than a hypothetical pathophysiological link be-
tween the two affections [4].Conclusion
We ﬁnd that there is no correlation between COPD and
OSAHS. The latter is a risk factor for the ﬁrst.
Conﬂicts of interest
None.
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